We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.35%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$24.3B
AUM Growth
-$663M
(-2.7%)
Cap. Flow
-$1.37B
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
15.29%
Holding
1,567
New
158
Increased
553
Reduced
532
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$130M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$126M |
| 3 |
MetLife
MET
|
+$107M |
| 4 |
General Mills
GIS
|
+$92.4M |
| 5 |
Parker-Hannifin
PH
|
+$71.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 2 |
RTN
Raytheon Company
RTN
|
+$151M |
| 3 |
Delta Air Lines
DAL
|
+$148M |
| 4 |
Norfolk Southern
NSC
|
+$145M |
| 5 |
Boston Scientific
BSX
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.12% |
| 2 | Financials | 14.48% |
| 3 | Technology | 13.69% |
| 4 | Consumer Discretionary | 8.63% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$5T
| $733M | 3.02% |
23,560,364
-254,260
| -1% | -$7.68M |
|
2
Gilead Sciences
GILD
$166B
| $433M | 1.78% |
4,411,458
+513,928
| +13% | +$52.2M |
|
3
Amgen
AMGN
$210B
| $429M | 1.77% |
2,682,701
+235,659
| +10% | +$37.1M |
|
4
Pfizer
PFE
$144B
| $384M | 1.58% |
11,628,570
-355,822
| -3% | -$11.3M |
|
|
5
Johnson & Johnson
JNJ
$645B
| $355M | 1.46% |
3,524,635
+1,278,648
| +57% | +$130M |
|
6
JPMorgan Chase
JPM
$927B
| $311M | 1.28% |
5,141,322
-9,770
| -0.2% | -$579K |
|
7
Oracle
ORCL
$339B
| $290M | 1.19% |
6,713,337
-304,670
| -4% | -$13.2M |
|
8
Alphabet (Google) Class C
GOOG
$4.09T
| $275M | 1.13% |
10,004,171
-666,004
| -6% | -$17.8M |
|
9
Merck
MRK
$324B
| $251M | 1.03% |
4,576,401
+658,226
| +17% | +$37.3M |
|
10
Wells Fargo
WFC
$257B
| $249M | 1.03% |
4,579,171
+14,172
| +0.3% | +$766K |
|
11
ExxonMobil
XOM
$652B
| $247M | 1.02% |
2,908,335
-36,996
| -1% | -$3.28M |
|
12
UBS Group
UBS
$170B
| $215M | 0.89% |
11,403,517
-460,978
| -4% | -$8.02M |
|
13
Microsoft
MSFT
$2.92T
| $206M | 0.85% |
5,063,906
-538,185
| -10% | -$23.4M |
|
14
Northrop Grumman
NOC
$77.2B
| $195M | 0.8% |
1,212,605
-156,640
| -11% | -$25M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $187M | 0.77% |
1,619,215
+96,318
| +6% | +$11.5M |
|
16
Baxter International
BAX
$12.7B
| $186M | 0.77% |
4,991,697
+169,435
| +4% | +$6.42M |
|
17
Kroger
KR
$37B
| $183M | 0.75% |
4,763,382
-95,756
| -2% | -$3.42M |
|
18
Biogen
BIIB
$31.1B
| $176M | 0.73% |
417,977
+43,974
| +12% | +$17.3M |
|
|
AET
19
DELISTED
Aetna Inc
AET
| $169M | 0.7% |
1,590,381
-282,704
| -15% | -$27.7M |
|
20
HP
HPQ
$26B
| $168M | 0.69% |
11,843,470
-131,041
| -1% | -$2.16M |
|
|
YHOO
21
DELISTED
Yahoo Inc
YHOO
| $166M | 0.68% |
3,727,567
+208,139
| +6% | +$9.41M |
|
|
CNH
22
CNH Industrial
CNH
$13.4B
| $160M | 0.66% |
22,530,553
-895,125
| -4% | -$6.16M |
|
23
Travelers Companies
TRV
$82.3B
| $157M | 0.65% |
1,453,470
-110,539
| -7% | -$11.8M |
|
|
DFS
24
DELISTED
Discover Financial Services
DFS
| $153M | 0.63% |
2,715,932
-142,233
| -5% | -$8.42M |
|
25
Intel
INTC
$416B
| $148M | 0.61% |
4,732,427
-54,494
| -1% | -$1.84M |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q1 2015 Portfolio in Review
As of Q1 2015, Axa held 1,567 positions worth $24.3B, down 2.7% from $24.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Axa withdrew a net $1.37B in Q1 2015, closing 145 positions and reducing 532 holdings. Its most notable exit was Viatris, an estimated $55.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
Against the trend, Axa opened a new position in Nasdaq worth $42.1M.
- Axa's largest Q1 2015 buy was Nasdaq: 2,480,223 shares worth $42.1M.
- Axa added most to Johnson & Johnson in Q1 2015, an estimated $130M increase.
- Axa's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $199M.
- Axa fully exited Viatris in Q1 2015, selling an estimated $55.8M.
- Axa's ten largest holdings make up 15% of its $24.3B portfolio in Q1 2015.
- Axa opened 158 new positions and closed 145 in Q1 2015.
- Axa's portfolio value fell 2.7% quarter-over-quarter to $24.3B.
Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.